Mending broken hearts: Cardiac development as a basis for adult heart regeneration and repair

Nature Reviews Molecular Cell Biology

Volumn 14, Issue 8, 2013, Pages 529-541

  Xin, Mei ^a   Olson, Eric N ^a   Bassel Duby, Rhonda ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR 1; HELIX LOOP HELIX PROTEIN; MICRORNA; NEU DIFFERENTIATION FACTOR; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HAND2; UNCLASSIFIED DRUG; WNT PROTEIN;

ANGIOGENESIS; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL DIVISION; CELL MIGRATION; CELL PROLIFERATION; DNA REPLICATION; DNA SYNTHESIS; EMBRYO DEVELOPMENT; FIBROBLAST; HEART DEVELOPMENT; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION SYSTEM; HEART REGENERATION; HUMAN; M PHASE CELL CYCLE CHECKPOINT; MAMMAL CELL; NEURAL TUBE; NONHUMAN; NOTOCHORD; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REGENERATION; REVIEW; SIGNAL TRANSDUCTION; STOICHIOMETRY; TRANSCRIPTION REGULATION; TURNOVER TIME; UPREGULATION; WNT SIGNALING PATHWAY; ZEBRA FISH;

ADULT; ANIMALS; EMBRYONIC DEVELOPMENT; HEART; HUMANS; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; REGENERATION; REGENERATIVE MEDICINE; WOUND HEALING;

MAMMALIA; RODENTIA;

EID: 84880839534     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm3619     Document Type: Review

References (114)

1. Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T. & Murray, C. J. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 367, 1747-1757 2006
2. Hill, J. A. & Olson, E. N. Cardiac plasticity. N. Engl. J. Med. 358, 1370-1380 2008
3. Segers, V. F. & Lee, R. T. Stem-cell therapy for cardiac disease. Nature 451, 937-942 2008
4. Laflamme, M. A. & Murry, C. E. Heart regeneration. Nature 473, 326-335 2011
5. Wollert, K. C. & Drexler, H. Cell therapy for the treatment of coronary heart disease: A critical appraisal. Nature Rev. Cardiol. 7, 204-215(2010
6. Anversa, P., Kajstura, J., Rota, M. & Leri, A. Regenerating new heart with stem cells. J. Clin. Invest. 123, 62-70 2013
7. Passier, R., van Laake, L. W. & Mummery, C. L. Stem-cell-based therapy and lessons from the heart. Nature 453, 322-329 2008
8. Ptaszek, L. M., Mansour, M., Ruskin, J. N. & Chien, K. R. Towards regenerative therapy for cardiac disease. Lancet 379, 933-942 2012
9. Mercola, M., Ruiz-Lozano, P. & Schneider, M. D. Cardiac muscle regeneration: Lessons from development. Genes Dev. 25, 299-309 2011
10. Buckingham, M., Meilhac, S. & Zaffran, S. Building the mammalian heart from two sources of myocardial cells. Nature Rev. Genet. 6, 826-835 2005
11. Olson, E. N. Gene regulatory networks in the evolution and development of the heart. Science 313, 1922-1927 2006
12. Srivastava, D. Making or breaking the heart: From lineage determination to morphogenesis. Cell 126, 1037-1048 2006
13. Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386 2010
14. Qian, L. et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485, 593-598 2012
15. Song, K. et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485, 599-604 2012
16. Aguirre, A., Sancho-Martinez, I. & Izpisua Belmonte, J. C. Reprogramming toward heart regeneration: Stem cells and beyond. Cell Stem Cell 12, 275-284 2013
17. Engel, F. B. et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 19, 1175-1187 2005
18. Kuhn, B. et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nature Med. 13, 962-969 2007
19. Bersell, K., Arab, S., Haring, B. & Kuhn, B. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138, 257-270 2009
20. Heallen, T. et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332, 458-461 2011
21. Xin, M. et al. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci. Signal. 4, ra70 2011
22. von Gise, A. et al. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc. Natl Acad. Sci. USA 109, 2394-2399 2012
23. Porrello, E. R. et al. MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ. Res. 109, 670-679 2011
24. Eulalio, A. et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492, 376-381 2012
25. Garcia-Martinez, V. & Schoenwolf, G. C. Primitive-streak origin of the cardiovascular system in avian embryos. Dev. Biol. 159, 706-719 1993
26. Tam, P. P., Parameswaran, M., Kinder, S. J. & Weinberger, R. P. The allocation of epiblast cells to the embryonic heart and other mesodermal lineages: The role of ingression and tissue movement during gastrulation. Development 124, 1631-1642 1997
27. Garry, D. J. & Olson, E. N. A common progenitor at the heart of development. Cell 127, 1101-1104 2006
28. Bruneau, B. G. Signaling and transcriptional networks in heart development and regeneration. Cold Spring Harb. Perspect. Biol. 5, a008292 2013
29. Ahuja, P., Sdek, P. & MacLellan, W. R. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol. Rev. 87, 521-544 2007
30. Li, F., Wang, X., Capasso, J. M. & Gerdes, A. M. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell. Cardiol. 28, 1737-1746 1996
31. Maillet, M., van Berlo, J. H. & Molkentin, J. D. Molecular basis of physiological heart growth: Fundamental concepts and new players. Nature Rev. Mol. Cell Biol. 14, 38-48 2013
32. Bergmann, O. et al. Evidence for cardiomyocyte renewal in humans. Science 324, 98-102 2009
33. Kajstura, J. et al. Cardiomyogenesis in the adult human heart. Circ. Res. 107, 305-315 2010
34. Senyo, S. E. et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493, 433-436 2013
35. Poss, K. D., Wilson, L. G. & Keating, M. T. Heart regeneration in zebrafish. Science 298, 2188-2190 2002
36. Lepilina, A. et al. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 127, 607-619 2006
37. Jopling, C. et al. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 464, 606-609 2010
38. Kikuchi, K. et al. Primary contribution to zebrafish heart regeneration by gata4+ cardiomyocytes. Nature 464, 601-605 2010
39. Fishman, M. C. & Olson, E. N. Parsing the heart: Genetic modules for organ assembly. Cell 91, 153-156 1997
40. Wills, A. A., Holdway, J. E., Major, R. J. & Poss, K. D. Regulated addition of new myocardial and epicardial cells fosters homeostatic cardiac growth and maintenance in adult zebrafish. Development 135, 183-192 2008
41. Porrello, E. R. et al. Transient regenerative potential of the neonatal mouse heart. Science 331, 1078-1080 2011
42. Porrello, E. R. et al. Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc. Natl Acad. Sci. USA 110, 187-192 2013
43. Pasumarthi, K. B. & Field, L. J. Cardiomyocyte cell cycle regulation. Circ. Res. 90, 1044-1054 2002
44. Chaudhry, H. W. et al. Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium. J. Biol. Chem. 279, 35858-35866 2004
45. Pasumarthi, K. B., Nakajima, H., Nakajima, H. O., Soonpaa, M. H. & Field, L. J. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ. Res. 96, 110-118 2005
46. Katz, E. B. et al. Cardiomyocyte proliferation in mice expressing α-cardiac myosin heavy chain-SV40 T-antigen transgenes. Am. J. Physiol. 262, H1867-H1876 1992
47. Kubin, T. et al. Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell 9, 420-432 2011
48. Engel, F. B., Hsieh, P. C., Lee, R. T. & Keating, M. T. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc. Natl Acad. Sci. USA 103, 15546-15551 2006
49. Liang, Q. & Molkentin, J. D. Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: Dichotomy between cultured myocytes and animal models. J. Mol. Cell. Cardiol. 35, 1385-1394 2003
50. Cuevas, P. et al. Fibroblast growth factor-1 prevents myocardial apoptosis triggered by ischemia reperfusion injury. Eur. J. Med. Res. 2, 465-468 1997
51. Grego-Bessa, J. et al. Notch signaling is essential for ventricular chamber development. Dev. Cell 12, 415-429 2007
52. Liu, N. & Olson, E. N. MicroRNA regulatory networks in cardiovascular development. Dev. Cell 18, 510-525 2010
53. Small, E. M. & Olson, E. N. Pervasive roles of microRNAs in cardiovascular biology. Nature 469, 336-342 2011
54. Hullinger, T. G. et al. Inhibition of miR-15 protects against cardiac ischemic injury. Circ. Res. 110, 71-81 2012
55. Pan, D. The Hippo signaling pathway in development and cancer. Dev. Cell 19, 491-505 2010
56. Zhao, B., Tumaneng, K. & Guan, K. L. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nature Cell Biol. 13, 877-883 2011
57. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 2006
58. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 2007
59. Marchetto, M. C. et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143, 527-539 2010
60. Lee, G. et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402-406 2009
61. Zhang, J. et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 8, 31-45 2011
62. Liu, G. H. et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472, 221-225 2011
63. Yazawa, M. et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471, 230-234 2011
64. Carvajal-Vergara, X. et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465, 808-812 2010
65. Priori, S. G., Napolitano, C., Di Pasquale, E. & Condorelli, G. Induced pluripotent stem cell-derived cardiomyocytes in studies of inherited arrhythmias. J. Clin. Invest. 123, 84-91 2013
66. Nakamura, K., Hirano, K. & Wu, S. M. iPS cell modeling of cardiometabolic diseases. J. Cardiovasc. Transl. Res. 6, 46-53 2013
67. Bellin, M., Marchetto, M. C., Gage, F. H. & Mummery, C. L. Induced pluripotent stem cells: The new patient? Nature Rev. Mol. Cell Biol. 13, 713-726 2012
68. Yoshida, Y. & Yamanaka, S. iPS cells: A source of cardiac regeneration. J. Mol. Cell. Cardiol. 50, 327-332 2011
69. Efe, J. A. et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nature Cell Biol. 13, 215-222 2011
70. Islas, J. F. et al. Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors. Proc. Natl Acad. Sci. USA 109, 13016-13021 2012
71. Jugdutt, B. I. Ventricular remodeling after infarction and the extracellular collagen matrix: When is enough enough? Circulation 108, 1395-1403 2003
72. Chen, J. X. et al. Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ. Res. 111, 50-55 2012
73. Addis, R. C. et al. Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. J. Mol. Cell. Cardiol. 60, 97-106 2013
74. Jayawardena, T. M. et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res. 110, 1465-1473 2012
75. Evans, S. M., Tai, L. J., Tan, V. P., Newton, C. B. & Chien, K. R. Heterokaryons of cardiac myocytes and fibroblasts reveal the lack of dominance of the cardiac muscle phenotype. Mol. Cell. Biol. 14, 4269-4279 1994
76. Takeuchi, J. K. & Bruneau, B. G. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 459, 708-711 2009
77. Minasi, M. G. et al. The meso-angioblast: A multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129, 2773-2783 2002
78. Acharya, A. et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 139, 2139-2149 2012
79. Nam, Y. J. et al. Reprogramming of human fibroblasts toward a cardiac fate. Proc. Natl Acad. Sci. USA 110, 5588-5593 2013
80. Kapoor, N., Galang, G., Marban, E. & Cho, H. C. Transcriptional suppression of connexin43 by TBX18 undermines cell-cell electrical coupling in postnatal cardiomyocytes. J. Biol. Chem. 286, 14073-14079 2011
81. Rentschler, S. et al. Myocardial Notch signaling reprograms cardiomyocytes to a conduction-like phenotype. Circulation 126, 1058-1066 2012
82. Wang, Z., Wang, D. Z., Pipes, G. C. & Olson, E. N. Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl Acad. Sci. USA 100, 7129-7134 2003
83. Chen, J., Kitchen, C. M., Streb, J. W. & Miano, J. M. Myocardin: A component of a molecular switch for smooth muscle differentiation. J. Mol. Cell. Cardiol. 34, 1345-1356 2002
84. Du, K. L. et al. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol. Cell. Biol. 23, 2425-2437 2003
85. Li, S., Wang, D. Z., Wang, Z., Richardson, J. A. & Olson, E. N. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc. Natl Acad. Sci. USA 100, 9366-9370 2003
86. Pipes, G. C., Creemers, E. E. & Olson, E. N. The myocardin family of transcriptional coactivators: Versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 20, 1545-1556 2006
87. Margariti, A. et al. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc. Natl Acad. Sci. USA 109, 13793-13798 2012
88. Kurian, L. et al. Conversion of human fibroblasts to angioblast-like progenitor cells. Nature Methods 10, 77-83 2013
89. Ginsberg, M. et al. Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression. Cell 151, 559-575 2012
90. Sucov, H. M., Gu, Y., Thomas, S., Li, P. & Pashmforoush, M. Epicardial control of myocardial proliferation and morphogenesis. Pediatr. Cardiol. 30, 617-625 2009
91. Zhou, B. et al. Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J. Clin. Invest. 121, 1894-1904 2011
92. Katz, T. C. et al. Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells. Dev. Cell 22, 639-650 2012
93. Majesky, M. W. Development of coronary vessels. Curr. Top. Dev. Biol. 62, 225-259 2004
94. Red-Horse, K., Ueno, H., Weissman, I. L. & Krasnow, M. A. Coronary arteries form by developmental reprogramming of venous cells. Nature 464, 549-553 2010
95. Huang, G. N. et al. C/EBP transcription factors mediate epicardial activation during heart development and injury. Science 338, 1599-1603 2012
96. Rinkevich, Y. et al. Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature. Nature Cell Biol. 14, 1251-1260 2012
97. Acharya, A., Baek, S. T., Banfi, S., Eskiocak, B. & Tallquist, M. D. Efficient inducible Cre-mediated recombination in Tcf21 cell lineages in the heart and kidney. Genesis 49, 870-877 2011
98. Kikuchi, K. et al. tcf21+ epicardial cells adopt non-myocardial fates during zebrafish heart development and regeneration. Development 138, 2895-2902 2011
99. Russell, J. L., Goetsch, S. C., Aguilar, H. R., Frantz, D. E. & Schneider, J. W. Targeting native adult heart progenitors with cardiogenic small molecules. ACS Chem. Biol. 7, 1067-1076 2012
100. Heredia, J. E. et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 153, 376-388 2013
101. Kharraz, Y., Guerra, J., Mann, C. J., Serrano, A. L. & Munoz-Canoves, P. Macrophage plasticity and the role of inflammation in skeletal muscle repair. Mediators Inflamm. 2013, 491497 2013
102. Saclier, M., Cuvellier, S., Magnan, M., Mounier, R. & Chazaud, B. Monocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration. FEBS J. http://dx.doi.org/10.1111/febs.12166 2013
103. Frangogiannis, N. G. The immune system and cardiac repair. Pharmacol. Res. 58, 88-111 2008
104. Swirski, F. K. & Nahrendorf, M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339, 161-166 2013
105. Swirski, F. K. et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612-616 2009
106. Nahrendorf, M., Pittet, M. J. & Swirski, F. K. Monocytes: Protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121, 2437-2445 2010
107. Kyritsis, N. et al. Acute inflammation initiates the regenerative response in the adult zebrafish brain. Science 338, 1353-1356 2012
108. Lee, J. et al. Activation of innate immunity is required for efficient nuclear reprogramming. Cell 151, 547-558 2012
109. Kawamura, M. et al. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126, S29-S37 2012
110. Chen, H. S., Kim, C. & Mercola, M. Electrophysiological challenges of cell-based myocardial repair. Circulation 120, 2496-2508 2009
111. Zhang, Y. M., Hartzell, C., Narlow, M. & Dudley, S. C. Jr. Stem cell-derived cardiomyocytes demonstrate arrhythmic potential. Circulation 106, 1294-1299 2002
112. Lee, R. J., Hinson, A., Helgerson, S., Bauernschmitt, R. & Sabbah, H. N. Polymer-based restoration of left ventricular mechanics. Cell Transplant. 22, 529-533 2013
113. Badylak, S. F., Taylor, D. & Uygun, K. Whole-organ tissue engineering: Decellularization and recellularization of three-dimensional matrix scaffolds. Annu. Rev. Biomed. Eng. 13, 27-53 2011
114. Zhang, R. et al. In vivo cardiac reprogramming contributes to zebrafish heart regeneration. http://dx.doi.org/10.1038/nature12322 2013 Research Program